ANTARES PHARMA INC's ticker is and the CUSIP is 36642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $9,000 | +50.0% | 5,455 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | 0.0% | 5,455 | -26.8% | 0.00% | – |
| Q1 2016 | $6,000 | 0.0% | 7,455 | +51.5% | 0.00% | – |
| Q4 2015 | $6,000 | -96.8% | 4,922 | -95.5% | 0.00% | -100.0% |
| Q3 2015 | $186,000 | -27.6% | 109,122 | -11.8% | 0.00% | -25.0% |
| Q2 2015 | $257,000 | +78.5% | 123,680 | +133.2% | 0.00% | +100.0% |
| Q1 2015 | $144,000 | +37.1% | 53,043 | +30.2% | 0.00% | 0.0% |
| Q4 2014 | $105,000 | +23.5% | 40,743 | -12.2% | 0.00% | +100.0% |
| Q3 2014 | $85,000 | -18.3% | 46,397 | +18.9% | 0.00% | -50.0% |
| Q2 2014 | $104,000 | -71.5% | 39,020 | -62.6% | 0.00% | -66.7% |
| Q1 2014 | $365,000 | -39.2% | 104,273 | -22.1% | 0.01% | -33.3% |
| Q4 2013 | $600,000 | +31.9% | 133,860 | +19.4% | 0.01% | 0.0% |
| Q3 2013 | $455,000 | – | 112,109 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|